In this Phase III hypercholesterolemia study, AMR Clinical sites enrolled 14% of total trial participants across just 12% of study locations, exceeding enrollment targets and delivering a high retention rate. All AMR sites opened ahead of schedule. Enrollment exceeded diversity benchmarks, contributing strongly to program-level goals for representation by race and gender.
Read this case study to explore how AMR Clinical delivered:
- High-performing enrollment across 6 early-opening sites
- Retention and open-label extension participation rates
- Diversity goals across population groups